| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Trulieve Cannabis Corp.$8.53
-0.5 (-5.48%)
Market Cap
-
EPS
-
P/E Ratio
-
Value Trade
-
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
12.35 K
Monthly Burn
12.35 K
Runway
12,345 mo
Overview
Volume
2.53 M
52 Week Range
-
% held by Insiders
15.56 %
% held by Institutions
5.4 %
Enterprise Value
-
Total Shares
167.85 M
Short %
-
Float Shares
159.07 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in TRLV
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
Trulieve Cannabis Corp. (TRLV) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
TRLV
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
TRLV
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
TRLV
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
TRLV Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
TRLV Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-TRLV
May 7, 2026Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation First quarter revenue of $287 million, with 59% gross margin Positive net income of $2 million and Adjusted EBITDA of $
Trulieve Cannabis Corp. reported a profitable first quarter of 2026 with revenue of $287 million, achieving a gross margin of 59%. The company also generated positive net income of $2 million and adjusted EBITDA of $100 million. Cash flow from operations was notable at $56 million, with a strong cash position of $353 million at quarter's end. The rescheduling of medical marijuana to Schedule III is expected to open new business opportunities for Trulieve as they expand their retail and operational footprint in various states.
Read more →-TRLV
Feb 26, 2026Trulieve Reports Fourth Quarter and Full Year 2025 Results with 60% Gross Margin and Record Cash Flow Generation Full year revenue of $1.2 billion, with 60% gross margin Record 2025 cash flow from operations of $273 mill
Trulieve Cannabis Corp. has released its financial results for the fourth quarter and full year ended December 31, 2025, reporting full year revenues of $1.2 billion, with a gross margin of 60%. Despite these achievements, the company faced a net loss of $116 million for the year. Key operational highlights include generating record cash flow from operations of $273 million and successfully growing its rewards program to 915,000 members. Management expressed optimism about future growth opportunities as they navigate the market landscape.
Read more →-TRLV
Dec 17, 2025Document Trulieve Announces Closing of US$140 Million Private Placement of 10.5% Senior Secured Notes
Trulieve Cannabis Corp. has announced the closing of a private placement of 10.5% Senior Secured Notes due 2030, raising US$140 million in gross proceeds. The company intends to use the net proceeds for capital expenditures and general corporate purposes. The interest on the notes is payable semi-annually, and they are expected to mature on December 17, 2030. This fundraising effort reflects market demand as the offering size was increased accordingly.
Read more →-TRLV
Dec 9, 2025Document Trulieve Announces US$100 Million Private Placement of 10.5% Senior Secured Notes TALLAHASSEE, Fla. - December 8 2025 - Trulieve Cannabis Corp. (CSE TRUL) (OTCQX TCNNF) ("Trulieve" or "the Company"), a leading a
Trulieve Cannabis Corp. has announced a private placement of 10.5% Senior Secured Notes, expected to raise US$100 million. The Notes are due in 2030 and will be issued at face value. Proceeds from the offering will be utilized for capital expenditures and corporate purposes. The offering is anticipated to close by December 17, 2025, pending regulatory approval. Notably, the Notes will not be registered under the Securities Act, targeting qualified institutional buyers and certain non-U.S. persons for the sale.
Read more →-TRLV
Nov 5, 2025Trulieve Reports Third Quarter 2025 Results Demonstrating Operational Discipline and Cash Flow Strength Third quarter revenue of $288 million, with 59% gross margin Year to date cash flow from operations of $214 million
Trulieve Cannabis Corp. reported its third quarter 2025 financial results, showcasing a revenue of $288 million with a gross margin of 59%. Despite these promising figures, the company incurred a net loss of $27 million, though an adjusted net loss of $12 million was reported after excluding non-recurring charges. The company emphasized its operational discipline and cash flow strength, generating $214 million in cash flow from operations year-to-date. Trulieve also unveiled various product launches and expansions, underlining its growth trajectory in the cannabis market.
Read more →-TRLV
Nov 4, 2025Document Trulieve Announces Notice of Redemption for All US$368 Million of its 8.0% Senior Secured Notes due 2026
Trulieve Cannabis Corp. has announced the redemption of its outstanding 8.0% senior secured notes due 2026, totaling US$368 million. The redemption will occur on December 5, 2025, at 100% of the principal amount plus accrued interest. This decision reflects the company's strategy to manage debt effectively, indicating a solid financial standing. The notes will be delisted from the Canadian Securities Exchange following the redemption.
Read more →-TRLV
Aug 6, 2025Trulieve Reports Second Quarter 2025 Results Highlighting Progress on 2025 Plan Second quarter revenue of $302 million, with 61% gross margin Cash flow from operations of $137 million and free cash flow of $108 million*
Trulieve Cannabis Corp. has released its financial results for the second quarter of 2025, reporting revenues of $302 million and a gross margin of 61%. The company increased its cash flow from operations to $137 million and launched new product lines, contributing to a growth in branded product sales. Despite this progress, Trulieve experienced a net loss of $14 million, illustrating challenges in profitability relative to operational expansion. The firm continues to execute its 2025 plan with an enhanced focus on customer engagement and product distribution.
Read more →-TRLV
May 7, 2025Trulieve Reports First Quarter 2025 Results Demonstrating Core Business Strength First quarter revenue of $298 million, with 62% gross margin Cash flow from operations of $51 million and free cash flow of $34 million* 4
Trulieve Cannabis Corp. reported its financial results for Q1 2025, demonstrating robust core business performance with a revenue of $298 million and a gross margin of 62%. Despite achieving positive cash flows and EBITDA growth, the company incurred a net loss of $33 million. The operational highlights include a significant increase in traffic and revenue from loyalty program members, alongside the launch of a new THC beverage product. However, rising operating expenses raise concerns about ongoing profitability.
Read more →-TRLV
Mar 7, 2025Document Trulieve Announces Appointment of Ryan Blust as Interim Chief Financial Officer
Trulieve Cannabis Corp. has appointed Ryan Blust as interim Chief Financial Officer following the departure of Wes Getman, effective March 6, 2025. Blust, who has been with the company since 2018, is expected to guide the financial team during this transition while Trulieve seeks a permanent CFO. The company highlighted its commitment to financial robustness and growth in the cannabis industry, particularly in states like Florida and Arizona, amid ongoing expansion efforts.
Read more →-TRLV
Feb 27, 2025Trulieve Reports Fourth Quarter and Full Year 2024 Results Highlighting Margins and Cash Flow Fourth quarter revenue of $301 million, up 5% year over year, exceeding guidance Gross margin of 62%, compared to 54% during t
Trulieve Cannabis Corp. reported its fourth quarter and full year 2024 financial results, highlighting significant revenue growth and improved gross margins. The company achieved a record cash flow from operations of $271 million and expanded its retail footprint with the opening of 33 new dispensaries. However, it also reported a net loss of $60 million for Q4 and a total loss of $155 million for the year. The results indicate a mixed performance with operational improvements overshadowed by substantial losses.
Read more →-TRLV
Nov 5, 2024Trulieve Reports Third Quarter 2024 Results Ahead of Florida Adult-Use Vote Third quarter revenue of $284 million, up 3% year over year, in line with guidance Gross margin of 61%, compared to 52% during the third quarter
Trulieve Cannabis Corp. reported third quarter 2024 financial results with revenues of $284 million, marking a 3% increase year-over-year. The company experienced an improvement in gross margin, rising to 61% from 52% in the previous year. However, Trulieve also reported a significant net loss of $60 million, attributed to increased operational support for adult-use cannabis campaigning in Florida. Despite these losses, adjusted EBITDA showed a positive trend, increasing 24% year over year to $96 million, highlighting operational efficiency improvements.
Read more →-TRLV
Aug 6, 2024Trulieve Reports Second Quarter 2024 Results Exceeding Quarterly Guidance Second quarter performance of $303 million in revenue, up 2% sequentially and 8% year over year, and 60% gross margin Launched Adult Use Sales in
Trulieve Cannabis Corp. has reported its financial results for the second quarter of 2024, showcasing a revenue of $303 million, which reflects both sequential and year-over-year growth. The gross margin improved to 60%, and the company launched adult use sales in Ohio. However, despite these positive developments, Trulieve posted a net loss of $12 million, though this was an improvement compared to previous quarters. This quarter marks the company's 200th retail location opening as it celebrates its eight-year milestone since its initial sale.
Read more →-TRLV
May 9, 2024Trulieve Reports First Quarter 2024 Results Demonstrating Core Business Strength and Cash Generation First quarter performance of $298 million in revenue, up 4% sequentially, and 58% gross margin Strong cash flow from op
Trulieve Cannabis Corp. reported its first-quarter results for 2024, highlighting a revenue increase to $298 million, representing a 4% sequential growth. The company achieved a gross margin of 58% and a notable 35% rise in adjusted EBITDA year-over-year. Although the net loss was reduced to $23 million from $64 million, the company noted ongoing operational costs. CEO Kim Rivers expressed optimism about the company's future growth potential, citing significant catalysts ahead.
Read more →-TRLV
Feb 29, 2024Trulieve Reports Fourth Quarter and Full Year 2023 Results Highlighting Year End Momentum and Cash Generation Fourth quarter performance delivered highest revenue and gross margin for the year Record cash flow from opera
Trulieve Cannabis Corp. reported its fourth quarter and full year 2023 results, highlighting significant year-end momentum and cash generation. The company achieved its highest revenue and gross margin for the year, with approximately $208 million in cash as of December 31, 2023. It also announced successful expansions into new markets and maintained a focus on cash preservation and resilience. However, the company experienced a notable increase in net loss and a decline in total revenue for the year, raising concerns about overall profitability.
Read more →-TRLV
Dec 1, 2023Trulieve Announces Completion of Redemption of All US$130 Million 9.75% Senior Secured Notes due 2024 Tallahassee, Fla.
Trulieve Cannabis Corp. has completed the redemption of its outstanding US$130 million 9.75% senior secured notes due in 2024. The company utilized approximately US$136 million for the redemption, which includes accrued interest. This move signals Trulieve's commitment to managing its financial obligations and could positively impact investor sentiment. The redeemed notes will cease trading on the Canadian Securities Exchange as of December 1, 2023.
Read more →-TRLV
Nov 8, 2023Trulieve Announces Notice of Redemption for All US$130 Million of its 9.75% Senior Secured Notes due 2024 Tallahassee, Fla.
Trulieve Cannabis Corp. has announced the redemption of its outstanding 9.75% senior secured notes totaling US$130 million, with a redemption date set for December 1, 2023. This decision is part of the company's strategy to manage its debt and improve financial health. The redemption price will be 100% of the principal, plus any accrued interest. Following the redemption, the notes will be delisted from the Canadian Securities Exchange, emphasizing Trulieve's commitment to maintaining a robust financial position as it continues to grow in the cannabis market.
Read more →-TRLV
Oct 13, 2023Trulieve Announces Filing of Amended Federal Tax Returns Claiming $143 Million Refund Tallahassee, Fla.
Trulieve Cannabis Corp. has filed amended federal tax returns for 2019, 2020, and 2021, claiming a total refund of $143 million. The company believes it does not owe this amount due to interpretations challenging its tax liability under Section 280E of the Internal Revenue Code. However, there is no assurance that the IRS will approve these refund claims, and the announcement includes forward-looking statements that highlight potential risks and uncertainties. Trulieve continues to position itself as a leading cannabis operator in the U.S. market.
Read more →-TRLV
Sep 21, 2023Trulieve Announces Purchase of 8% Senior Secured Notes due 2026 Tallahassee, Fla.
Trulieve Cannabis Corp. has announced the open market purchase of 57,000 of its senior secured notes due in 2026, totaling $47.6 million, which reflects a 16.5% discount to par. Trulieve, recognized as a leading cannabis company in the United States, is making this strategic move to bolster its financial standing. The company is focused on growth and expansion in key markets such as Arizona, Florida, and Pennsylvania, emphasizing its innovative product offerings.
Read more →-TRLV
Aug 9, 2023Trulieve Reports Second Quarter 2023 Results Highlighting Progress on 2023 Plan Sold 11.6 million units of branded product through branded retail, up 9% sequentially Maryland dispensary traffic increased 200% in July wit
Trulieve Cannabis Corp. reported its second quarter 2023 results, demonstrating a robust demand for cannabis products with sales of 11.6 million branded units. However, the company faced a 10% decline in revenue compared to the same quarter last year, resulting in a net loss of $404 million. Despite the financial challenges, management expressed confidence in their strategy and operational efficiency, citing a notable increase in Maryland dispensary traffic. The company aims to reposition itself for better prospects as the year closes.
Read more →-TRLV
Jul 21, 2023Trulieve Announces Appointment of Ryan Blust as Interim Chief Financial Officer
Trulieve Cannabis Corp. has appointed Ryan Blust as its interim Chief Financial Officer following the departure of Tim Mullany for personal reasons, effective July 20, 2023. Blust, who has been with the company since 2018 and has previous experience as interim CFO, brings over 18 years of finance expertise. Trulieve is also in the process of recruiting a permanent CFO, aiming to ensure a seamless transition and capitalize on its growth potential in the cannabis market.
Read more →-TRLV
Jun 19, 2023Trulieve Announces Appointment of Tim Mullany as Chief Financial Officer
Trulieve Cannabis Corp. announced the appointment of Tim Mullany as Chief Financial Officer, effective July 10, 2023. Mullany brings over 20 years of experience from various sectors, including serving as CFO at both Jack in the Box Inc. and RAVE Restaurant Group. He replaces Alex D'Amico, who resigned from the position. CEO Kim Rivers expressed optimism about Mullany joining Trulieve during a pivotal growth period for the company, which has established a strong presence in the U.S. cannabis market.
Read more →-TRLV
May 10, 2023Trulieve Reports First Quarter 2023 Results Marking Progress on Cash Objectives Record 4/20 results with traffic, customers served, and units sold up 10%, 11%, and 9%, respectively, year over year Cost reduction initiati
Trulieve Cannabis Corp. reported its first-quarter results for 2023, revealing a 9% decrease in revenue year-over-year to $289 million. CEO Kim Rivers emphasized the company's focus on cash preservation and adaptation to evolving market conditions, despite an increase in net loss to $64 million from $32 million a year prior. Additionally, the company reported a 17% drop in gross profit, reflecting ongoing operational challenges, even as certain metrics like customer traffic showed improvement during the 4/20 season.
Read more →-TRLV
Mar 8, 2023Trulieve Reports Fourth Quarter and Record Full Year 2022 Results Exceeding $1.2 Billion in Revenue Record revenue of $1.24 billion in 2022, up 32% year over year, and quarterly revenue of $302 million, with 2% retail re
Trulieve Cannabis Corp. reported record financial results for 2022, achieving over $1.2 billion in revenue, which represents a 32% increase from the previous year. Although the company faced a net loss of $81.2 million in the fourth quarter, they have outlined a focus on cash generation and sustainable growth in the coming year. The CEO highlighted the potential for further expansion in the U.S. cannabis market, attributing their success to effective management and execution. The company plans to enhance its operational capabilities while navigating significant industry challenges.
Read more →-TRLV
Dec 21, 2022Trulieve Announces Closing of $71.5 Million Financing
Trulieve Announces Closing of $71.5 Million Financing TALLAHASSEE, Fla. December 21, 2022 Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ( Trulieve or the Company ), a leading and top-performing cannabis company in the U.S., today announced the closing of a commercial loan
Read more →-TRLV
Nov 9, 2022Trulieve Reports Third Quarter 2022 Results and Drives Forward Progress on Strategic Vision Revenue increased 34% year over year to $301 million with GAAP gross margin of 56% Industry leading U.S. retail network of 176 d
Trulieve Reports Third Quarter 2022 Results and Drives Forward Progress on Strategic Vision Tallahassee, FL November 9, 2022 Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ( Trulieve or the Company ), a leading and top-performing cannabis company in the U.S., today announc
Read more →-TRLV
Aug 10, 2022Trulieve Delivers Record Second Quarter 2022 Results Driven by Organic Retail Sales Revenue of $320.3 million, up 49% year over year and 1% sequentially Retail revenue grew 3% sequentially across industry leading U.S. ne
Trulieve Delivers Record Second Quarter 2022 Results Driven by Organic Retail Sales Tallahassee, FL August 10, 2022 Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ( Trulieve or the Company ), a leading and top-performing cannabis company in the U.S., today announced its re
Read more →-TRLV
May 12, 2022Trulieve Starts Year with Record First Quarter 2022 Results Record revenue of $318.3 million, up 64% year over year and 4% sequentially First quarter 2022 cash flow from operations of $45.1 million and cash balance of $2
Trulieve Starts Year with Record First Quarter 2022 Results Tallahassee, FL May 12, 2022 Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ( Trulieve or the Company ), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended
Read more →-TRLV
Mar 30, 2022Trulieve Caps Transformational Year with Record Fourth Quarter and Full Year 2021 Results Record revenue of $938.4 million in 2021, up 80% year over year, and quarterly revenue of $305.3 million, up 36% sequentially Indu
Trulieve Caps Transformational Year with Record Fourth Quarter and Full Year 2021 Results Tallahassee, FL March 30, 2022 Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ( Trulieve or the Company ), a leading and top-performing cannabis company in the U.S., today announced i
Read more →-TRLV
Jan 28, 2022Trulieve Announces Closing of $75 Million Private Placement of 8% Senior Secured Notes
Trulieve Announces Closing of $75 Million Private Placement of 8% Senior Secured Notes TALLAHASSEE, Fla. Jan. 28, 2022 Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ( Trulieve or the Company ), a leading and top-performing cannabis company in the U.S., today announced that
Read more →-TRLV
Nov 15, 2021Trulieve Reports Record Third Quarter 2021 Results and 15 th Consecutive Profitable Quarter Continues Execution of Hub Strategy with Harvest Acquisition U.S. Leader with 155 Retail Dispensaries 3.5 Million Square Feet of
Trulieve Reports Record Third Quarter 2021 Results and 15th Consecutive Profitable Quarter Continues Execution of Hub Strategy with Harvest Acquisition U.S. Leader with 155 Retail Dispensaries 3.5 Million Square Feet of Cultivation and Processing Capacity Tallahassee, FL Nov
Read more →-TRLV
Oct 6, 2021Trulieve Announces Closing of $350 Million Private Placement of 8% Senior Secured Notes
Trulieve Announces Closing of $350 Million Private Placement of 8% Senior Secured Notes TALLAHASSEE, Fla., October 6, 2021 /CWN/ Trulieve Cannabis Corp. ( Trulieve or the Company ) (CSE: TRUL) (OTCQX: TCNNF) today announced that it has closed its previously announced private p
Read more →-TRLV
Oct 1, 2021Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms "Trulieve," "we," "us" and "our" in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certai
CSE: TRUL OTCQX: TCNNF ir@trulieve.com Investor Presentation October 2021 Exhibit 99.1 Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms "Trulieve," "we," "us" and "our" in this presentation refer to Trulieve Cannabis Corp
Read more →-TRLV
Oct 1, 2021Trulieve Completes Acquisition of Harvest Health & Recreation Inc. Creating the Largest and Most Profitable U.S. Cannabis Operator Combined Company Platform Poised for Accelerated Growth Industry Leading Footprint in Cor
Trulieve Completes Acquisition of Harvest Health & Recreation Inc. Creating the Largest and Most Profitable U.S. Cannabis Operator Combined Company Platform Poised for Accelerated Growth Industry Leading Footprint in Cornerstone Markets Expanded Runway for Growth in Northeast
Read more →-TRLV
Sep 30, 2021Trulieve Announces $350 Million Private Placement of 8% Senior Secured Notes Leverages Industry Leading Balance Sheet to Provide for Retirement of Certain Harvest Health & Recreation Debt Upon Completion of Acquisition
Trulieve Announces $350 Million Private Placement of 8% Senior Secured Notes Leverages Industry Leading Balance Sheet to Provide for Retirement of Certain Harvest Health & Recreation Debt Upon Completion of TALLAHASSEE, Fla., September 30, 2021 /CWN/ Trulieve Cannabis Corp. (
Read more →-TRLV
Aug 15, 2021Live without Investor Presentation limits. August 2021 Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms "Trulieve," "we," "us" and "our" in this prospectus refer to
2021Exhibit 99.1 Live without Investor Presentation limits. August 2021 Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms "Trulieve," "we," "us" and "our" in this prospectus refer to Trulieve Cannabis Corp. and its subsidia
Read more →-TRLV
Aug 12, 2021Trulieve Reports Record Second Quarter 2021 Earnings and Expansion into New Markets Achieved a number of firsts and records including 14 th consecutive quarter of profitability and over 500,000 customers served; Became t
Trulieve Reports Record Second Quarter 2021 Earnings and Expansion into New Markets Achieved a number of firsts and records including 14th consecutive quarter of profitability and over 500,000 customers served; Became the first medical cannabis operator to start planting in Wes
Read more →-TRLV
Jun 4, 2021Relief you can rely on Investor Presentation | June 2021 Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms "Trulieve," "we," "us" and "our" in this prospectus refer
2021Exhibit 99.1 Relief you can rely on Investor Presentation | June 2021 Forward Looking Statements and Industry and Market Data Unless the context otherwise requires, the terms "Trulieve," "we," "us" and "our" in this prospectus refer to Trulieve Cannabis Corp. and its subsid
Read more →-TRLV
May 13, 2021Trulieve Reports Record First Quarter 2021 Revenue of $193.8M, Net Income of $30.1M and Adjusted EBITDA of $90.8M Achieved 13 th consecutive quarter of profitability; Announces definitive agreement to acquire Harvest Hea
Trulieve Reports Record First Quarter 2021 Revenue of $193.8M, Net Income of $30.1M and Adjusted EBITDA Achieved 13th consecutive quarter of profitability; Announces definitive agreement to acquire Harvest Health & Recreation Inc., one of the largest US cannabis acquisitions to
Read more →-TRLV
May 10, 2021Forward Looking Statement Forward-looking statements made in this document are made only as of the date of their initial publication, and the Company undertakes no obligation to publicly update any of these forward-looki
Investor Presentation | May 2021 & Creation of the Most Profitable MSO Exhibit 99.1 Forward Looking Statement Forward-looking statements made in this document are made only as of the date of their initial publication, and the Company undertakes no obligation to publicly update
Read more →-TRLV
Mar 23, 2021Trulieve Reports Fourth Quarter and Full-Year 2020 Results and Announces Full-Year 2021 Guidance Builds on national expansion and achieves 12 th consecutive quarters of profitability. Tallahassee, FL
Trulieve Reports Fourth Quarter and Full-Year 2020 Results and Announces Full-Year 2021 Guidance Builds on national expansion and achieves 12th consecutive quarters of profitability. Tallahassee, FL March 23, 2021 Trulieve Cannabis Corp. ( Trulieve or the Company ) (CSE: TRUL
Read more →Competitive Position
How TRLV ranks across every disease it competes inCompetitive Position is a premium feature
See how TRLV ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial